Struggling with epitope specificity, structural instability, or low developability in antibody discovery?
Synbio Technologies offers an AI-powered antibody discovery platform that combines single B-cell screening, diverse antibody libraries, and structure-based AI optimization—delivering high-affinity, development-ready candidates with speed and precision.


 
Tackling Today’s Challenges with Tomorrow’s Technology
✔ Challenge: Epitope Uncertainty?
Our AI prediction algorithms pinpoint optimal antigen-binding sites for superior specificity.

✔ Challenge: Poor Developability?
We apply deep learning and molecular dynamics to optimize structure and boost manufacturability.

✔ Challenge: Bottlenecked Structural Insights?
With advanced modeling tools, we accelerate structural predictions—no crystallography delays needed.
 
Quote Now            Learn More


Additionally, our VIP customers enjoy access to a range of premium services:
Gene Synthesis Virus Packaging RNAi Synthesis
Antibody Services Gene Editing Peptide Services
 
 
Synbio Technologies LinkedIn X Facebook Facebook

Thank you for connecting with us! Click "Subscribe" to receive valuable insights and news. If you prefer not to receive further emails, just hit "Unsubscribe" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA